Doç. Dr. FATİH ÖZDENER

Makaleler 49

1. Response to "Changing Prescriptions May Distort Nutritional Adherence Associations in Children with Cancer".

Kantar M., Bıçaklı D. H., Sürsal A., Özkan E., Özdener F.

Nutrition and cancer , ss.1-2, 2026 (SCI-Expanded, Scopus)

2. Adherence to Oral Nutritional Support and Its Effect on Nutritional Status in Pediatric Oncology Patients

Kantar M., Bicakli D. H., ÖZKAN A., Ilhan I., TAÇYILDIZ N., Kebudi R., et al.

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL , cilt.78, sa.2, ss.145-157, 2026 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

3. Evaluation of the Impact of Enteral Nutrition Support on Anthropometric Measurements and Micronutrient Levels in Malnourished Children

Arsoy H. A., Aghazada G., Demirtas Z., Sursal A., Korkudur M. N. P., Ozdener F.

CLINICAL PEDIATRICS , cilt.64, sa.7, ss.913-923, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

4. Measuring and Evaluating the Adherence to and Effectiveness of Formula Milk Use in Healthy Infants in Türkiye

ÖZDENER F., KILIÇ İ., SAF C., BİLEN T. D., ÇELİK D., URAŞ N., et al.

Forbes tıp dergisi (Online) , cilt.4, 2023 (TRDizin)

5. Factors affecting formula compliance of infants with IgE mediated cow's milk protein allergy during the pandemic

KOCACIK UYGUN D. F., Karaatmaca B., TOPAL E., Arga M., Sancakli O., ÖZCAN D., et al.

FRONTIERS IN ALLERGY , cilt.4, 2023 (ESCI, Scopus)

6. Global bibliometric analysis of publications on COVID-19 in newborns

BARUTÇU ., ALKAN S., Barutcu S., Ozdener F., UYAR C.

CUKUROVA MEDICAL JOURNAL , cilt.48, sa.4, ss.1265-1274, 2023 (ESCI, TRDizin)

7. Factors Affecting Prognosis in the Course of Pediatric Celiac Disease

GÜLCÜ TAŞKIN D., Sursal A., Dogan A. E., Ozdener F.

CUREUS JOURNAL OF MEDICAL SCIENCE , cilt.14, sa.12, 2022 (ESCI)

8. Evaluation of Nutritional Status and Anxiety Levels in Patients Applying to the Radiation Oncology Outpatient Clinic during the COVID-19 Pandemic: Turkish Society for Radiation Oncology Group Study (TROD 12:02)

YÜRÜT ÇALOĞLU V., Akmansu M., YALMAN D., KARABULUT GÜL Ş., KOÇAK Z., Alicikus Z. A., et al.

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL , cilt.74, sa.10, ss.3601-3610, 2022 (SCI-Expanded, Scopus)

9. Effect of Rotavirus Infection on Serum Micronutrients and Atopy in Children

Basaran M. K., Dogan C., Sursal A., Ozdener F.

JOURNAL OF PEDIATRIC INFECTIOUS DISEASES , cilt.17, sa.03, ss.137-142, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

10. Comparison of Isocaloric and Hypercaloric Diet in Undernourished Patients

BARUTÇU ., Barutcu S., Dogan A. E., Ozdener F., TÜMGÖR G., EVLİYAOĞLU N.

JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN , cilt.32, sa.1, ss.61-67, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

11. Evaluation of Anxiety, Depression and Burden on Caregivers of Children with Cerebral Palsy

BARUTÇU ., Barutcu S., Kolkiran S., Ozdener F.

DEVELOPMENTAL NEUROREHABILITATION , cilt.24, sa.8, ss.555-560, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

12. Evaluation of parameters associated with growth retardation in children with coeliac disease

GÜLCÜ TAŞKIN D., Sursal A., Dogan A. E., Ozdener F.

JOURNAL OF PAEDIATRICS AND CHILD HEALTH , cilt.57, sa.9, ss.1454-1459, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

13. Percutaneous Endoscopic Gastrostomy Feeding in Children with Cerebral Palsy

Civan H. A., Bektas G., Dogan A. E., Ozdener F.

NEUROPEDIATRICS , cilt.52, sa.04, ss.326-332, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

14. A Phase II Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab and Chemoradiotherapy in the Adjuvant Setting in Operated Patients With HER2-positive Gastric or Gastroesophageal Junction Cancer (TOXAG Study) A Turkish Oncology Group Study

Abali H., YALÇIN Ş., Onal H. C., Dane F., ÇAKMAK ÖKSÜZOĞLU Ö. B., ÖZDEMİR N., et al.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , cilt.44, sa.7, ss.301-307, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

15. Klinik Farmakolojide Vaka Temelli Öğrenmenin Konvansiyonel Öğretim Şekli ile Kıyaslanması ve Öğrenme Stilleri ile İlişkisi

ozdener F., Ozbaykus A. C., Yavuz M., Sürsal A., Narter F., KOC D.

Southern Clinics of Istanbul Eurasia , cilt.31, sa.3, ss.208-213, 2020 (TRDizin)

16. Effects of hypercaloric enteral intervention on malnutrition patients with a history of febrile seizure before the age of six

SİLİSTRE SÜNNETÇİ E., ÖZPENPE Ö., HATİPOĞLU H. U., DOĞAN A., ÖZDENER F.

Journal of Surgery and Medicine , cilt.4, sa.9, ss.738-742, 2020 (Hakemli Dergi)

17. Enteral feed based gradual improvement of body mass index and normalization of micronutrients in children with malnutrition

KEÇELİ BAŞARAN M., ZENGİN N., DOĞAN A., SURSAL A., ÖZDENER F.

Journal of Surgery and Medicine , cilt.4, sa.9, ss.826-829, 2020 (Hakemli Dergi)

18. Factors Associated with Treatment Adherence in Children with Malnutrition in Turkey

Ozdener F., Kirbiyik F., Dogan A. E., Baygul A.

International Journal of Nutrition, Pharmacology, Neurological Diseases , cilt.10, sa.3, ss.105-111, 2020 (Scopus)

19. Development of Clinical Trials in Turkey After the Adoption of Clinical Drug Research Regulation

ÖZDENER F., SURSAL A., NARTER K. F.

Southern Clinics of Istanbul Eurasia , cilt.31, sa.2, ss.171-176, 2020 (TRDizin)

20. Elements of Treatment Adherence in Children with Cow’s Milk Protein Allergy

ÖZDENER F., KIRBIYIK F., AKŞİT A., DOĞAN A. E., BAYGÜL A., GÜLER N., et al.

INTERNATIONAL JOURNAL OF NUTRITION, PHARMACOLOGY, NEUROLOGICAL DISEASES , cilt.10, sa.1, ss.1-7, 2020 (Scopus)

21. Current Status of Urological Surgery Clinical Trials in the Middle East and Its Analysis in Comparison to Global

Ozdener F., Sursal A., Narter F.

JOURNAL OF UROLOGICAL SURGERY , cilt.6, sa.4, ss.266-272, 2019 (ESCI, TRDizin) Sürdürülebilir Kalkınma

22. Analysis of nutrition clinical studies involving children in the Middle East and globally

Ozdener F., Kirbiyik F., Dogan A. E.

FUTURE SCIENCE OA , cilt.4, sa.9, 2018 (ESCI, Scopus) Sürdürülebilir Kalkınma

23. Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study

Koksal I., YILMAZ G., PARLAK M., Demirdal T., Kinikli S., Candan M., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.29, sa.4, ss.464-472, 2018 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

24. Subcutaneous CERA for the Treatment of Chronic Renal Anemia in Predialysis Patients

ÜSTÜNDAĞ S., Dogan E., DURANAY M., KAZANCIOĞLU R., Celik V., Unsal A., et al.

BALKAN MEDICAL JOURNAL , cilt.33, sa.3, ss.322-330, 2016 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

25. Factors affecting breast cancer treatment delay in Turkey: a study from Turkish Federation of Breast Diseases Societies

Ozmen V., Boylu S., Ok E., CANTÜRK N. Z., Celik V., Kapkac M., et al.

EUROPEAN JOURNAL OF PUBLIC HEALTH , cilt.25, sa.1, ss.9-14, 2015 (SCI-Expanded, SSCI, Scopus) Sürdürülebilir Kalkınma

26. Once-monthly continuous erythropoietin receptor activator (CERA) for haemoglobin maintenance in haemodialysis patients with chronic renal anaemia

Duman N., UYANIK A., Unsal A., Sezer S., Camsari T., Cirit M., et al.

CLINICAL KIDNEY JOURNAL , cilt.7, sa.5, 2014 (ESCI, Scopus) Sürdürülebilir Kalkınma

27. A cross-sectional survey of the diagnosis and management of bone metastasis in breast cancer patients in Turkey

Arican A., Bozkurt T., Bozcuk H., DEMİRKAN H. M. B., Buyukberber S., Alkis N., et al.

SUPPORTIVE CARE IN CANCER , cilt.22, sa.10, ss.2629-2634, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

28. The association between insulin resistance and hepatic fibrosis in patients with chronic hepatitis C: An observational, multicenter study in Turkey

Dokmeci A., Ustundag Y., Hulagu S., Tuncer I., Akdogan M., Demirsoy H., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.25, sa.5, ss.546-552, 2014 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

29. Epidemiologic study on HER2 (+) early/advanced stage gastric cancer: An evaluation on HER2 positivity in gastric and gastroesophageal junction cancers

ERDAMAR ÇETİN A. S., KEPİL N., Dursun A., Ekinci O., Sagol O., Sarioglu S., et al.

VIRCHOWS ARCHIV , cilt.465, 2014 (SCI-Expanded, Scopus)

30. In Situ Hybridization Analysis of Invasive Breast Carcinomas with Immunohistochemically Negative Her-2 Status (A National Multicenter Study)

Tuzlali S., Yavuz E., Canda T., GÜRAY DURAK M., Ozgun Gecer M., Süllü Y., et al.

TURKISH JOURNAL OF PATHOLOGY , cilt.30, sa.2, ss.87-93, 2014 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

31. A candidate identification questionnaire for postmenopausal osteoporosis patients switched from daily or weekly bisphosphonate to once-monthly ibandronate: An open, prospective, multicenter study—BONCURE study

Kutsal Y. G., Eskiyurt N., Irdesel J., Sepici V., Ugurlu H., Kirazli Y., et al.

Health , cilt.5, sa.07, ss.30-40, 2013 (Hakemli Dergi)

32. Bevacizumab plus Capecitabine as Maintenance Therapy after Initial Bevacizumab plus XELOX Treatment in Previously Untreated Patients with Metastatic Colorectal Cancer: Phase Ill 'Stop and Go' Study Results - A Turkish Oncology Group Trial

YALÇIN Ş., Uslu R., Dane F., Yilmaz U., Zengin N., Buyukunal E., et al.

ONCOLOGY , cilt.85, sa.6, ss.328-335, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

33. Association of insulin resistance, viral load, and adipokine levels with liver histology in patients with chronic hepatitis C: an observational, multicenter study in Turkey

Aksu H. S. Z., Kurtaran B., ÖNLEN Y., Namiduru M., Inkaya A. C., Kandemir O., et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , cilt.24, sa.12, ss.1393-1399, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

34. Günlük veya haftalık alendronat veya risendronat alan postmenopozal osteoporozlu kadınlarda aylık ibandronat için hasta tercihinin değerlendirildiği açık- etiketli, prospektif, çok-merkezi, iki-aşamalı çalışma-BONCURE: Türkiye alt-çalışması

eskiyurt n., İRDESEL J., SEPİCİ V., UĞURLU H., Kirazlı Y., Yukruk F. A., et al.

Türk Osteoporoz Dergisi , cilt.18, sa.1, ss.1-7, 2012 (TRDizin)

35. Open, Prospective, Multi-Center, Two-Part Study of Patient Preference with Monthly Ibandronate Therapy in Women with Postmenopausal Osteoporosis Switched From Daily or Weekly Alendronate or Risendronate-BONCURE: Results of Turkish Sub-Study

Eskiyurt N., Irdesel J., Sepici V., Ugurlu H., Kirazli Y., Ardic F., et al.

TURK OSTEOPOROZ DERGISI-TURKISH JOURNAL OF OSTEOPOROSIS , cilt.18, sa.1, ss.1-7, 2012 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

36. Calcium channel blockers increase the amount of nitrite production in rabbits without decreasing the responsiveness of platelets to collagen

SIRMAGÜL B., Ozdener F., Gulbas Z., Erol K.

CLINICAL AND EXPERIMENTAL MEDICINE , cilt.7, sa.4, ss.142-148, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

37. 5-Hydroxytryptamine-2A receptor gene (HTR2A) candidate polymorphism T102C): Role for human platelet function under pharmacological challenge ex vivo

Özdener F., Gülbas Z., Erol K., Ozdemir V.

METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY , cilt.27, sa.6, ss.395-400, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

38. Fasidotril Eli Lilly

Ozdener F., Ozdemir V.

Current Opinion in Investigational Drugs , cilt.4, sa.9, ss.1113-1119, 2003 (Scopus)

39. Activation of phospholipase Cγ2 by tyrosine phosphorylation

Özdener F., Dangelmaier C., Ashby B., Kunapuli S., Daniel J.

MOLECULAR PHARMACOLOGY , cilt.62, sa.3, ss.672-679, 2002 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

40. Expression of enzymatically-active phospholipase Cγ2 in E-coli

Ozdener F., Kunapuli S., Daniel J.

JOURNAL OF BIOCHEMISTRY AND MOLECULAR BIOLOGY , cilt.35, sa.5, ss.508-512, 2002 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

41. Glycoprotein VI-mediated platelet fibrinogen receptor activation occurs through calcium-sensitive and PKC-sensitive pathways without a requirement for secreted ADP

Quinton T., Ozdener F., Dangelmaier C., Daniel J., Kunapuli S.

BLOOD , cilt.99, sa.9, ss.3228-3234, 2002 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

42. Aripiprazole Otsuka Pharmaceutical Co

Ozdemir V., Fourie J., Özdener F.

Current Opinion in Investigational Drugs , cilt.3, sa.1, ss.113-120, 2002 (Scopus)

43. Carboxyl terminal sequence of human phospholipase Cγ2

Ozdener F., Kunapuli S., Daniel J.

PLATELETS , cilt.12, sa.2, ss.121-123, 2001 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

44. Molecular mechanism of glycoprotein VI-mediated platelet activation.

Ozdener F., Quinton T., Kunapuli S.

BLOOD , cilt.96, sa.11, 2000 (SCI-Expanded, Scopus)

45. Activation of PLCγ2 by tyrosine phosphorylation.

Ozdener F., Dangelmaier C., Ashby B., Kunapuli S., Daniel J.

BLOOD , cilt.96, sa.11, 2000 (SCI-Expanded, Scopus)

46. Studies on platelet activation by collagen: Expression of enzymatically active phospholipase C-gamma-2 in E. coli

Ozdener F., Kunapuli S., Smith J., Daniel J.

THROMBOSIS AND HAEMOSTASIS , ss.636, 1999 (SCI-Expanded, Scopus)

47. Functional role of the spatial proximity of Asp114(2.50) in TMH2 and Asn332(7.49) in TMH7 of the μopioid receptor

Xu W., Ozdener F., Li J., Chen C., de Riel J., Weinstein H., et al.

FEBS LETTERS , cilt.447, sa.2-3, ss.318-324, 1999 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

48. Studies on platelet activation by collagen: Expression of enzymatically active phospholipase-C gamma-2 in E-coli.

Ozdener F., Kunapuli S., Ashby B., Smith J., Daniel J.

BLOOD , cilt.92, sa.10, 1998 (SCI-Expanded, Scopus)

49. Trimetazidine does not reduce ischaemia-reperfusion induced arrhythmias in isolated perfused rat hearts

SÜZER Ö., ÖZKAN A. K., Ozdener F., Suzer A., Aykac Z., Ozuner Z.

BRITISH JOURNAL OF ANAESTHESIA , cilt.76, 1996 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 9

1. TREATMENT SATISFACTION, EXPECTATIONS, PATIENT PREFERENCES, AND CHARACTERISTICS IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA): TURKISH COHORT RESULTS OF THE SENSE STUDY

KALYONCU U., Kucuk A., Sargin G., Ozdener F., Yolba S., Yurttas B., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 2 - 05 Haziran 2021, cilt.80, ss.1470, (Özet Bildiri)

2. A study of the combination of oxaliplatin, capecitabine, and trastuzumab and chemo-radiotherapy in the adjuvant setting in operated patients with HER2+gastric or gastroesophageal junction cancer (TOXAG study).

Abali H., Yalcin S., Onal C., Dane F., ÇAKMAK ÖKSÜZOĞLU Ö. B., Ozdemir N., et al.

Gastrointestinal Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San-Francisco, Kostarika, 18 - 20 Ocak 2018, cilt.36, (Özet Bildiri) Sürdürülebilir Kalkınma

3. A study of the combination of oxaliplatin, capecitabine, and herceptin (trastuzumab) and chemoradiotherapy in the adjuvant setting in operated patients with HER2+gastric or gastro-esophageal junction cancer (TOXAG study).

Abali H., Yalcin S., Onal H. C., Dane F., ÇAKMAK ÖKSÜZOĞLU Ö. B., Ozdemir N., et al.

Gastrointestinal Cancers Symposium, San-Francisco, Kostarika, 21 - 23 Ocak 2016, cilt.34, (Özet Bildiri) Sürdürülebilir Kalkınma

4. Turkish Breast Cancer Registry: A multicenter epidemiologic study

Coskun U., Gumus M., Uncu D., Ozkan M., Cicin I., Altundag K., et al.

50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)

5. Factors affecting time to seeking medical advice and start of treatment in breast cancer (BC) patients in Turkey

Ozmen V., Boylu S., Ok E., CANTÜRK N. Z., Celik V., Kapkac M., et al.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)

6. Bevacizumab (BEV) plus capecitabine as maintenance therapy after initial treatment with BEV plus XELOX in previously untreated patients (pts) with metastatic colorectal cancer (mCRC): Mature data from STOP and GO, a phase III, randomized, multicenter study

Yalcin S., Uslu R., Dane F., Yilmaz U., Zengin N., Buyukunal E., et al.

48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30, (Özet Bildiri) Sürdürülebilir Kalkınma

7. A candidate-identification questionnaire for patients with postmenopausal osteoporosis switched from treatment with a daily or weekly bisphosphonate to once-monthly ibandronate

Kutsal Y. G., Eskiyurt N., Irdesel J., Sepici V., Ugurlu H., Kirazli Y., et al.

3rd Joint Meeting of the European-Calcified-Tissue-Society/International-Bone-and-Mineral-Society, Athens, Yunanistan, 7 - 11 Mayıs 2011, cilt.48, (Özet Bildiri)